Connect with us

CBD Industry

Square Opens Invite-Only Beta Testing for CBD Credit Card Payment Processing Program

Jane S

Published

on

Square Opens Invite-Only Beta Testing for CBD Credit Card Payment Processing Program

CBD businesses have been having trouble with payment processing on their websites. Credit card companies, such as Visa, notified CBD businesses that they will no longer be permitted to use the payment processor. In addition to payment processing, other challenges faced by CBD companies include maintaining bank accounts and receiving loans from financial institutions.

One company is moving to change things. Square, a payment processing platform, launched a new service for CBD businesses. A company spokesperson shared in an email with Forbes that

“Square is currently conducting an invite-only beta for some CBD products.”

The move seems to be in light of the changing policies concerning CBD. In any case, Squarely seems to have chosen the right time for its service.

During a hearing, Andy Barr discussed the struggles that businesses have been having when it comes to getting access to financial products. He stated during the hearing,

“I’ve had constituent businesses tell me that their access to financial products, specifically card services, have actually deteriorated since we descheduled industrial hemp in the Farm Bill. This obviously conflicts with congressional intent.”

Senators Ron Wyden and Mitch McConnel also sent letters to federal agencies requesting more guidance about financial service access for hemp businesses. The letter reads, in part,

“While some financial institutions have agreed to offer financial products to the growing hemp industry, many of them have not due to confusion over the legal status of hemp. However, as hemp is no longer a controlled substance, financial institutions should feel secure in engaging with this industry.”

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Join Us On Facebook

Trending CBD News

TimesofCBD always fact checks sources and aims for the best accuracy in the reporting curated cannabis content consisting of the latest CBD news, user guides and product health research. Quality is the priority, but we are not eligible to be liable as everything here is for educational, informational purposes only. Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

What Is CBD?

Copyright © 2019 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends: Telegram